Packard CJ - Search Results

1

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N; West of Scotland Coronary Prevention Study. Freeman DJ, et al. Among authors: packard cj. Diabetes. 2002 May;51(5):1596-600. doi: 10.2337/diabetes.51.5.1596. Diabetes. 2002. PMID: 11978661

2

Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease.

Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ. Deighan CJ, et al. Among authors: packard cj. J Am Soc Nephrol. 2001 Feb;12(2):341-348. doi: 10.1681/ASN.V122341. J Am Soc Nephrol. 2001. PMID: 11158224 Clinical Trial.

3

Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles.

Pirwany IR, Sattar N, Greer IA, Packard CJ, Fleming R. Pirwany IR, et al. Among authors: packard cj. Hum Reprod. 2002 Mar;17(3):825-9. doi: 10.1093/humrep/17.3.825. Hum Reprod. 2002. PMID: 11870144

4

Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.

Gaffney D, Forster L, Caslake MJ, Bedford D, Stewart JP, Stewart G, Wieringa G, Dominiczak M, Miller JP, Packard CJ. Gaffney D, et al. Among authors: packard cj. Atherosclerosis. 2002 May;162(1):33-43. doi: 10.1016/s0021-9150(01)00679-7. Atherosclerosis. 2002. PMID: 11947895

5

Influence of an asparagine to lysine mutation at amino acid 3516 of apolipoprotein B on low-density lipoprotein receptor binding.

Gaffney D, Pullinger CR, O'Reilly DS, Hoffs MS, Cameron I, Vass JK, Kulkarni MV, Kane JP, Schumaker VN, Watts GF, Packard CJ. Gaffney D, et al. Among authors: packard cj. Clin Chim Acta. 2002 Jul;321(1-2):113-21. doi: 10.1016/s0009-8981(02)00106-7. Clin Chim Acta. 2002. PMID: 12031600

6

A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics.

Ford I, Blauw GJ, Murphy MB, Shepherd J, Cobbe SM, Bollen EL, Buckley BM, Jukema JW, Hyland M, Gaw A, Lagaay AM, Perry IJ, Macfarlane P, Norrie J, Meinders AE, Sweeney BJ, Packard CJ, Westendorp RG, Twomey C, Stott DJ; The PROSPER Study Group. Ford I, et al. Among authors: packard cj. Curr Control Trials Cardiovasc Med. 2002 May 20;3(1):8. doi: 10.1186/1468-6708-3-8. Curr Control Trials Cardiovasc Med. 2002. PMID: 12097148 Free PMC article.

7

Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.

Forster LF, Stewart G, Bedford D, Stewart JP, Rogers E, Shepherd J, Packard CJ, Caslake MJ. Forster LF, et al. Among authors: packard cj. Atherosclerosis. 2002 Sep;164(1):129-45. doi: 10.1016/s0021-9150(02)00052-7. Atherosclerosis. 2002. PMID: 12119202 Clinical Trial.

8

Regulation of small dense LDL concentration in Korean and Scottish men and women.

Cho HK, Shin G, Ryu SK, Jang Y, Day SP, Stewart G, Packard CJ, Shepherd J, Caslake MJ. Cho HK, et al. Among authors: packard cj. Atherosclerosis. 2002 Sep;164(1):187-93. doi: 10.1016/s0021-9150(02)00058-8. Atherosclerosis. 2002. PMID: 12119209

9

Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS).

Streja L, Packard CJ, Shepherd J, Cobbe S, Ford I; WOSCOPS Group. Streja L, et al. Among authors: packard cj. Am J Cardiol. 2002 Oct 1;90(7):731-6. doi: 10.1016/s0002-9149(02)02599-7. Am J Cardiol. 2002. PMID: 12356386

10

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Shepherd J, et al. Among authors: packard cj. Lancet. 2002 Nov 23;360(9346):1623-30. doi: 10.1016/s0140-6736(02)11600-x. Lancet. 2002. PMID: 12457784 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters